Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

New Analyst Forecast: $RXRX Given $5.0 Price Target

None

We just received data on a new analyst forecast for $RXRX. Vikram Purohit from Recursion Pharmaceuticals set a price target of 5.0 for RXRX.

To track analyst ratings and price targets for $RXRX, check out Quiver Quantitative's $RXRX forecast page.

$RXRX Insider Trading Activity

$RXRX insiders have traded $RXRX stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $RXRX stock by insiders over the last 6 months:

  • CHRISTOPHER GIBSON (Chief Executive Officer) has made 0 purchases and 7 sales selling 258,574 shares for an estimated $1,699,186.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RXRX Hedge Fund Activity

We have seen 192 institutional investors add shares of $RXRX stock to their portfolio, and 109 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles